This study aimed to compare the performance of immunohistochemistry (IHC)‐based luminal subtyping of breast cancer against gene expression panels at our institute and to evaluate a CE‐certified artificial intelligence (AI) Ki67 image analysis program for improving subtyping accuracy. This evidence concerns the gene MKI67 and breast carcinoma.